Search for dissertations about: "Pharmaceutical industry"
Showing result 1 - 5 of 101 swedish dissertations containing the words Pharmaceutical industry.
-
1. Change in the Pharmaceutical Industry : Aspects on Innovation, Entrepreneurship, Openness, and Decision Making
Abstract : Over the past century, the pharmaceutical industry has been a major contributor of individual and population health and societal wealth. Its products and services have contributed to longevity of large groups of patients and symptom relief from major diseases. READ MORE
-
2. BPR in the Pharmaceutical Industry
Abstract : This thesis investigates the use of Business Process Reengineering (BPR) as a change approach in the Pharmaceutical Industry. The pharmaceutical industry is undergoing profound changes. New opportunities, e.g. READ MORE
-
3. Compression analysis as a tool for technical characterization and classification of pharmaceutical powders
Abstract : There are today strong incentives for an increased understanding of material properties and manufacturing processes to facilitate the development of new technologies in the pharmaceutical industry. The purpose of this thesis was to suggest methods requiring a low sample amount for characterization of technical properties of powders. READ MORE
-
4. Multivariate Synergies in Pharmaceutical Roll Compaction : The quality influence of raw materials and process parameters by design of experiments
Abstract : Roll compaction is a continuous process commonly used in the pharmaceutical industry for dry granulation of moisture and heat sensitive powder blends. It is intended to increase bulk density and improve flowability. READ MORE
-
5. Modelling and prediction of drug transport processes with experimental and calculated molecular properties : A multivariate approach
Abstract : Less than 2% of the lead compounds generated by the pharmaceutical industry enter the exploratory drug-development phase, from which point they stand only a 10% chance of becoming a commercial medicine. A large proportion of the compounds fail due to poor biopharmaceutical properties, such as permeability and solubility. READ MORE